Skip to content

Clinical value of nitrous oxide inhalation for endoscopic colonic polypectomy

Clinical value of nitrous oxide inhalation for endoscopic colonic polypectomy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021540
Enrollment
Unknown
Registered
2019-02-26
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polyp of colon

Interventions

Group 1:nitrous oxide inhalation
Group 2:propofol intravenous anesthesia
Group 3:non-anesthesia

Sponsors

The Third Affiliated Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: From December 2018 to December 2020, 90 patients, aged between 18 and 60 years old, who have been diagnosed with colonic polyps and planned to undergo endoscopic colonic polypectomy in the endoscopic center of our hospital were selected, and they all met ASA classification level I or level II. The number of colonic polyps was less than or equal to 3 and the diameter was less than or equal to 2.0cm.

Exclusion criteria

Exclusion criteria: 1. Severe cardiopulmonary insufficiency; 2. poor coagulation function, bleeding risk, or nearly 1 week to take anticoagulant or antiplatelet aggregation drugs; 3. Pregnant or lactating women; 4. Intestinal obstruction and perforation; 5. History of abdominal surgery; 6. Coma or mental disorder, unable to sign the informed consent or cooperate with the completion of the questionnaire; 7. Cerebral angiography was performed in the past week; 8. Have diving disease or have participated in diving activities recently; 9. A history of otitis media, sinusitis or septal surgery.

Design outcomes

Primary

MeasureTime frame
Preoperative, intraoperative and postoperative vital signs;Intraoperative and postoperative adverse reactions;sedative effect;Drug onset time;time of operation;recovery time;The hospitalized time;Physician and patient satisfaction;

Secondary

MeasureTime frame
Body Mass Index;age;gender;ASA classification;History of colonoscopy;Number of colonic polyps;Colonic polyp size;Position of colonic polyps;

Countries

China

Contacts

Public ContactYue Hui

The Third Affiliated Hospital of Southern Medical University

yh12070430@vip.sina.com+86 13926255688

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026